All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.
Philippe Armand and Roch Houot share information related to the recently launched COVID-HEME initiative including how hematologists can get involved.
COVID-HEME is a peer-to-peer forum for physicians about the care of patients with hematologic malignancies during the COVID-19 pandemic. The goal of this collaborative platform is to improve and accelerate the knowledge and experience of physicians to optimize the management of patients during the pandemic.
To join COVID-HEME, please ask for an invitation at email@example.com
COVID-HEME forum supports hematologists during COVID-19 pandemic
The impact of COVID-19 on the management of patients with multiple myeloma
An article, by Elena Zamagni, Paola Tacchetti, and Michele Cavo, discussing the impact of COVID-19 on the management of patients with multiple myeloma. SARS-CoV-2.
Clinical Advances in Myeloma 2019 | Overview Part II
The Clinical Advances in Myeloma 2019 conference, aimed to address the current management of patients with MM, with a particular focus on improving the outcomes for each patient group.
Subscribe to get the best content related to multiple myeloma delivered to your inbox